|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61F 9/00 |
| (11) | Number of the document | 3148491 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15728712.9 |
| Date of filing the European patent application | 2015-05-28 | |
| (97) | Date of publication of the European application | 2017-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/033036 |
| Date | 2015-05-28 |
| (87) | Number | WO 2015/184173 |
| Date | 2015-12-03 |
| (30) | Number | Date | Country code |
| 201462004824 P | 2014-05-29 | US |
| (72) |
HAFFNER, David, S., US
|
| (73) |
Glaukos Corporation,
229 Avenida Fabricante, San Clemente, CA 92672,
US
|
| (54) | IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND MANUFACTURING METHOD FOR SAID IMPLANTS |
| IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND MANUFACTURING METHOD FOR SAID IMPLANTS |